Rosa PhysioPD Research

Hear our story:

"This provides insights that are almost impossible to get any other way"

What's PhysioPD Research?

PhysioPD™ Research is a powerful Quantitative Systems Pharmacology (QSP) approach that translates the biology of interest into customized computer models that give credible insights that would be difficult or impractical to obtain in any other way. It is used by scientists and clinicians to clarify the connection between disease mechanisms, therapeutic interventions, and clinical outcomes. The result is a dramatic increase in confidence, and a reduction in risk in pharmaceutical and consumer product research and development.

Learn more about PhysioPD Research
What's PhysioPD Research?

Explore our Worldwide Webinar Series

Rosa’s "Impact" webinar series is renowned for its informative discussions on the use of computer modeling and simulation within the global research and development community. Register for an upcoming webinar or download a webinar from the archives.

Explore Webinars

Recent Highlights

Rosa & Co. Announces Strategic Research Agreement with Chugai Pharmaceutical Co., Ltd.

Rosa & Co. LLC, a drug development advisory firm known worldwide for its PhysioPD™ Research Platforms, today announced the initiation of a long-term Strategic Research Agreement with Chugai Pharmaceutical Co., Ltd. to provide Rosa’s PhysioPD rese... Read More

Sanofi and Rosa to Present Research Results at the 2019 ASCPT Annual Meeting

Rosa & Co. LLC, an organization known worldwide for its PhysioPD™ Research Platforms, announced today that it will present two research posters at the 2019 ASCPT Annual Meeting Pre-Conference, “Advancing QSP Toward Predictive Drug Development: Fr... Read More

Quantitative Systems Pharmacology Pioneers

Long before the world knew what to call ‘Quantitative Systems Pharmacology’ (QSP) in the realm of preclinical and clinical drug development, Ron Beaver, Founder, Chairman, and CEO of Rosa & Co. already had his moment of revelation. He realized th... Read More

Grünenthal and Rosa to present at the 2018 SID/IID dermatology meeting

Dr. Katherine Kudrycki, Principal Scientist at Rosa & Co, will present "Evaluation of a novel therapy and identification of uncertainties critical to efficacy and competitive differentiation in a Psoriasis PhysioPD™ Platform. " at the 2018 SID/II... Read More

"Rosa is all about doing better science"
—Christina Friedrich, PhD, Chief Engineer, PhysioPD
Learn about PhysioPD Research